KILIÇKAP, S. Et Al. 2018. Efficacy of Crizotinib in Patients with ALK Positive Advanced Stage Non-Small Cell Lung Cancer: A Real-World Experience from Turkey. 2th National Immunotherapy and Oncology Congress , (Antalya, Turkey).

KILIÇKAP, S., GÜRSOY, P., BUĞDAYCI BAŞOL, F., ÇAM, A., DEMİRCİ, U., ALAN, Ö., ... TATLI, A. M.(2018). Efficacy of Crizotinib in Patients with ALK Positive Advanced Stage Non-Small Cell Lung Cancer: A Real-World Experience from Turkey . 2th National Immunotherapy and Oncology Congress, Antalya, Turkey

KILIÇKAP, SAADETTİN Et Al. "Efficacy of Crizotinib in Patients with ALK Positive Advanced Stage Non-Small Cell Lung Cancer: A Real-World Experience from Turkey," 2th National Immunotherapy and Oncology Congress, Antalya, Turkey, 2018

KILIÇKAP, SAADETTİN Et Al. "Efficacy of Crizotinib in Patients with ALK Positive Advanced Stage Non-Small Cell Lung Cancer: A Real-World Experience from Turkey." 2th National Immunotherapy and Oncology Congress , Antalya, Turkey, 2018

KILIÇKAP, S. Et Al. (2018) . "Efficacy of Crizotinib in Patients with ALK Positive Advanced Stage Non-Small Cell Lung Cancer: A Real-World Experience from Turkey." 2th National Immunotherapy and Oncology Congress , Antalya, Turkey.

@conferencepaper{conferencepaper, author={SAADETTİN KILIÇKAP Et Al. }, title={Efficacy of Crizotinib in Patients with ALK Positive Advanced Stage Non-Small Cell Lung Cancer: A Real-World Experience from Turkey}, congress name={2th National Immunotherapy and Oncology Congress}, city={Antalya}, country={Turkey}, year={2018}}